At the news
? BEARISHIMPACT 4/10 SC 13G/A filed Nov 9, 2026 at 16:30 ET
Soleus Capital Master Fund filed an amended Schedule 13G for Inspire Medical Systems, reporting a 4.2% stake (1,206,828 shares) as of September 30, 2026. This is a decrease from the prior filing (Soleus Capital Master Fund previously reported a 5.0%+ stake in August 2026), indicating the fund reduced its position and fell below the 5% threshold. The filing remains passive (Rule 13d-1(c)), with no activist intent.
- Soleus Capital Master Fund reported 1,206,828 shares of INSP common stock, representing 4.2% of shares outstanding as of September 30, 2026.
- The percentage is based on 28,966,119 shares outstanding as of October 28, 2026, per the company's Form 10-Q.
- This is a decrease from the prior filing (August 13, 2026) where Soleus held a stake above 5%, indicating the fund reduced its position and fell below the 5% threshold.
- The filing is made under Rule 13d-1(c) (passive investor), with no intent to change or influence control.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access